Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei C Sposito

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Archives of Endocrinology and Metabolism|April 28, 2022
Who is to blame, the chicken or the egg?Andrei C Sposito
Atherosclerosis|July 14, 2016
HDL metrics, let's call the number thing off?Andrei C Sposito
Circulation. Cardiovascular Imaging|September 17, 2024
Accelerated Pace of Atherosclerosis in Steatotic Liver Disease: Implications for Risk StratificationAndrei C Sposito
European Heart Journal|May 14, 2022
Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular riskAndrei C Sposito
Revista Da Associacao Medica Brasileira (1992)|February 14, 2019
Diabetes and premature deathAndrei C Sposito, Carlos Serrano
International Journal of Cardiology|June 24, 2008
Association between suicide and cardiovascular disease: time series of 27 yearsAndrea Placido, Andrei C Sposito
Pharmacology & Therapeutics|January 25, 2008
Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapyM John Chapman, Andrei C Sposito
Atherosclerosis|January 1, 2013
Angiotensinogen gene polymorphism and HDL2 are linked to coronary artery calcification in individuals with family history of early coronary diseaseAndrei C Sposito, Raul D Santos
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefitAndrei C Sposito, M John Chapman
Cardiovascular Diabetology|October 24, 2014
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonistsFrancisco Kerr Saraiva, Andrei C Sposito
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Archives of Endocrinology and Metabolism|April 28, 2022
Who is to blame, the chicken or the egg?Andrei C Sposito
Atherosclerosis|July 14, 2016
HDL metrics, let's call the number thing off?Andrei C Sposito
Circulation. Cardiovascular Imaging|September 17, 2024
Accelerated Pace of Atherosclerosis in Steatotic Liver Disease: Implications for Risk StratificationAndrei C Sposito
European Heart Journal|May 14, 2022
Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular riskAndrei C Sposito
Revista Da Associacao Medica Brasileira (1992)|February 14, 2019
Diabetes and premature deathAndrei C Sposito, Carlos Serrano
International Journal of Cardiology|June 24, 2008
Association between suicide and cardiovascular disease: time series of 27 yearsAndrea Placido, Andrei C Sposito
Pharmacology & Therapeutics|January 25, 2008
Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapyM John Chapman, Andrei C Sposito
Atherosclerosis|January 1, 2013
Angiotensinogen gene polymorphism and HDL2 are linked to coronary artery calcification in individuals with family history of early coronary diseaseAndrei C Sposito, Raul D Santos
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefitAndrei C Sposito, M John Chapman
Cardiovascular Diabetology|October 24, 2014
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonistsFrancisco Kerr Saraiva, Andrei C Sposito
Pageof 26